浅谈乳腺肿物麦默通旋切术的操作经验  

Clinical experience of using Mammotome system in treatment of breast tumors

作　　者：徐泰[1] 李顺荣[1] 赖烨钤[1] 黄杰文[1] 丘冬琴 范苑林 李璐[1] 

机构地区：[1]梅州市人民医院乳腺外科,广东梅州514000

出　　处：《岭南现代临床外科》2014年第3期291-293,共3页Lingnan Modern Clinics in Surgery

摘　　要：目的总结麦默通手术病例,探讨乳腺肿物麦默通旋切术的操作经验。方法使用美国强生公司的麦默通微创旋切系统,在西门子彩超X150引导下对600例乳腺肿物患者行麦默通微创切除术,肿物切除后均送病理检查,并对患者进行术后1个月、3个月及6个月的随访。结果600例患者中,包括良性纤维腺瘤的508例,纤维囊性增生症22例,乳腺腺病51例,导管内乳头状瘤6例,浸润性乳腺癌8例,积乳5例。8例确诊为乳腺癌患者中,6例接受改良根治术,2例行保乳根治术。术中2例发现活动性出血,切开止血后痊愈;5例术后发生局部血肿,1例切开清除血肿,另外4例经抽吸血肿后加压包扎;皮下淤血9例,切破皮肤1例。510例得到随访,其中502例良性病变中,发现新发良性肿物5例,1例复发;8例诊断为乳腺癌患者,经规范治疗后随诊未见复发转移。结论麦默通微创旋切术对于良性乳腺肿物的切除是安全可行的,对于恶性肿物的活检提供了足量的病理标本,有助于明确诊断及进一步治疗。Objective To summarize experience in clinical practice of breast tunors by using ultrasound-guided Mammotome system. Methods 600 patients with breast lesions underwent the tumor resection by Mammotome biopsy system （Johnson ＆ Johnson US） and Siemens Ultrasound X150 from April 2012 to August 2013. The patients were followed up in one month, three months and six months after operation. Results Of the 600 cases, benign fibroadenoma was in 508 cases, benign fibrocystic breast disease in 22, adenosis of breast in 51, intraductal papilloma in 6, milk product in 5, invasive breast carcinoma in 8. In the breast carcinoma patients, 6 cases underwent modified radical mastectomy, 2 received breast conserving treatment. In postoperative complications, active bleeding occurred in 2 cases and underwent second operation, hematoma formation was found in 5 cases and treated by aspiration, large subcutaneous congestion was found in 9 cases and recovered by conservative treatment except incision and drainage. A total of 510 patients were followed up, in which 5 were found new tumor, 1 relapsed. None of the breast cancer patients were found recurrence and metastasis. Conclusion Mammotome atherectomy is safe and feasible for the benign breast tumor, and it can provide enough pathological specimens for the diagnosis and further treatment of the malignant tumor.

关 键 词：乳腺肿瘤 麦默通 活组织检查 

分 类 号：R655.8[医药卫生—外科学]